{"id":95386,"date":"2025-09-24T12:07:43","date_gmt":"2025-09-24T12:07:43","guid":{"rendered":"https:\/\/mailinvest.blog\/index.php\/2025\/09\/24\/the-white-house-kicks-tylenol-into-crisis-mode-again-will-its-pr-playbook-work-this-time\/"},"modified":"2025-09-24T12:08:38","modified_gmt":"2025-09-24T12:08:38","slug":"the-white-house-kicks-tylenol-into-crisis-mode-again-will-its-pr-playbook-work-this-time","status":"publish","type":"post","link":"https:\/\/mailinvest.blog\/index.php\/2025\/09\/24\/the-white-house-kicks-tylenol-into-crisis-mode-again-will-its-pr-playbook-work-this-time\/","title":{"rendered":"The White House Kicks Tylenol Into Crisis Mode Again. Will Its PR Playbook Work This Time?"},"content":{"rendered":"

<\/a>\n<\/p>\n

\n

Robert Andrews would perpetually keep in mind when his telephone rang on Friday, September 30, 1982. He was assistant director for PR at Johnson & Johnson, whose ache reliever, Tylenol, was the perfect recognized over-the-counter drug in America. On the opposite finish of the telephone was a\u00a0reporter from Chicago, on the lookout for a remark.<\/p>\n

\u201cHe instructed us that the health worker there had simply given a press convention\u2014folks have been dying from poisoned Tylenol,\u201d Andrews recalled<\/a> in a 1990 interview. \u201cIt was the primary data we had right here on this division. We instructed him we knew nothing about it.\u201d<\/p>\n

Manufacturers stay in terror of moments like these\u2014a sudden debacle that places their identify within the information, their popularity in query, and their future doubtful. Which is why, for Kenvue (the J&J spinoff that assumed custody of Tylenol in 2023), Monday\u2019s White Home press convention should have felt just like the worst sort of d\u00e9j\u00e0 vu.<\/p>\n

Announcing<\/a> that the Federal Drug Administration (FDA) would advise ladies to keep away from acetaminophen throughout being pregnant based mostly on a long-rumored however by no means substantiated threat of autism, President Trump singled the model out.<\/p>\n

\u201cTaking Tylenol is just not good,\u201d he mentioned. \u201cDon\u2019t take it, don\u2019t take it.\u201d<\/p>\n

The PR plight that Tylenol finds itself on this week is arguably its third\u2014a bitter capsule, contemplating the model did nothing to trigger any of them. What\u2019s extra, Kenvue\u2019s speedy drawback isn\u2019t simply yesterday\u2019s finger-pointing, however the man pointing the finger.<\/p>\n

\u201cKenvue is in a really troublesome place when a sitting president makes use of the White Home podium to discourage use of its flagship product,\u201d mentioned David Johnson, CEO of\u00a0 Strategic Imaginative and prescient PR Group, which makes a speciality of disaster communications. \u201cThe best counter is to not go toe-to-toe politically, however to lean arduous on science, security, and belief.\u201d<\/p>\n

Fortuitously, this can be a model with reserves of all three. <\/p>\n

Poison capsule<\/strong><\/h4>\n

The poisoned Tylenol episode of 1982\u2014the one which prompted Andrews\u2019 telephone to ring\u2014exploded on the nationwide scene when seven folks died after taking Further Power Tylenol capsules laced with potassium cyanide.\u00a0(Authorities by no means recognized the perpetrator.) <\/p>\n

To at the present time, enterprise faculties train J&J\u2019s response as a textbook instance of efficient disaster administration.\u00a0<\/p>\n

CEO James Burke instantly arrange an emergency technique group, which stood up a toll-free data quantity, labored carefully with the FBI, and ultimately recalled 31 million bottles of Tylenol. Inside six weeks, Burke\u2019s crew additionally rolled out tamper-proof packaging (as we speak customary for consumer-health manufacturers) and distributed coupons to 40 million folks encouraging them that Tylenol was protected to make use of.<\/p>\n

Extra bother would come knocking on Tylenol\u2019s door in 2010, when the FDA\u2014alarmed<\/a> by continual charges of unintended overdoses of acetaminophen\u2014required makers of the ache reliever so as to add a liver-damage warning to its packaging.<\/p>\n

<\/p>\n

No model needs to put on an indication warning of deadly harm, however right here once more J&J turned a hurdle into an opportunity to construct public belief in its model. Three years after the FDA\u2019s admonition, it voluntarily added an extra warning to Tylenol\u2019s cap that learn: \u201cAccommodates acetaminophen. All the time learn the label.\u201d <\/p>\n

In a ready assertion, the corporate mentioned that it \u201ctakes acetaminophen overdose very significantly, which is why we’ve got taken vital steps\u2026 to mitigate the chance.\u201d<\/p>\n

Tylenol\u2019s newest disaster<\/strong><\/h4>\n

Monday\u2019s announcement on the White Home has put the ache reduction capsule within the crosshairs as soon as once more. Kenvue responded rapidly with an announcement stressing that \u201ca decade of rigorous analysis\u2026confirms that there isn’t a credible proof linking acetaminophen with autism.\u201d <\/p>\n

However disaster communications specialists advocate that the corporate proceed to double down on its messaging.<\/p>\n

\u201cThe assertion was crucial, however fully inadequate when dealing with this degree of scrutiny,\u201d mentioned Evan Nierman, founder and CEO of disaster PR agency Pink Banyan. He instructed Tylenol coordinate with main medical associations, pharmacy chains, and OB-GYNs \u201cto create a unified entrance,\u201d and to take action \u201cwith the identical velocity and authority that made their 1982 tampering response the gold customary.\u201d<\/p>\n

\n
\n
\"The<\/a> <\/div>\n<\/section>\n<\/div>\n

Johnson supplied comparable counsel. Kenvue, he mentioned, ought to launch \u201ca coordinated, fact-based media and digital marketing campaign\u2014temporary, visible, and shareable\u2014underscoring FDA approval, doctor endorsements, and clear utilization steerage,\u201d he mentioned. With an authoritative, scientific rejoinder like this, \u201cKenvue can reframe the dialog round well being and security moderately than politics, whereas reassuring each the general public and traders.\u201d<\/p>\n

Burke, who died in 2012, can\u2019t give recommendation on this one, however his 1982 system of placing concern for customers earlier than the corporate did pay for itself. After shedding some $100 million on the recall and watching Tylenol\u2019s gross sales fall by a 3rd, inside 4 years the capsule was as soon as once more the main ache reliever in America.<\/p>\n

The speedy restoration even has a reputation: The Tylenol Impact.<\/p>\n<\/div>\n